Insider Transactions in Q4 2022 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,200
-25.1%
|
$67,600
$13.45 P/Share
|
|
Dec 29
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
400
-0.24%
|
$6,000
$15.01 P/Share
|
|
Dec 28
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
4,521
-2.61%
|
$67,815
$15.01 P/Share
|
|
Dec 27
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
9,669
-2.65%
|
$135,366
$14.92 P/Share
|
|
Dec 08
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,550
-21.61%
|
$81,900
$18.95 P/Share
|
|
Dec 08
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,550
+17.77%
|
$9,100
$2.1 P/Share
|
|
Dec 05
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-1.2%
|
$3,600
$18.05 P/Share
|
|
Dec 05
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.18%
|
$400
$2.1 P/Share
|
|
Dec 02
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,910
-14.99%
|
$52,380
$18.2 P/Share
|
|
Dec 02
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,910
+13.03%
|
$5,820
$2.1 P/Share
|
|
Nov 28
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.08%
|
$26,000
$13.91 P/Share
|
|
Nov 16
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-1.2%
|
$3,600
$18.1 P/Share
|
|
Nov 16
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.18%
|
$400
$2.1 P/Share
|
|
Oct 31
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
2,100
-4.43%
|
$50,400
$24.05 P/Share
|
|
Oct 27
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.07%
|
$42,000
$21.66 P/Share
|
|
Oct 26
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,960
-9.87%
|
$104,160
$21.61 P/Share
|
|
Oct 26
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,960
+16.19%
|
$9,920
$2.1 P/Share
|
|
Oct 25
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
12,061
-2.06%
|
$241,220
$20.76 P/Share
|
|
Oct 25
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
9,348
-5.76%
|
$186,960
$20.97 P/Share
|
|
Oct 25
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,040
-10.09%
|
$168,840
$21.36 P/Share
|
|
Oct 25
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,040
+21.85%
|
$16,080
$2.1 P/Share
|
|
Oct 24
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,342
-0.58%
|
$44,498
$19.28 P/Share
|
|
Oct 24
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
2,404
-2.05%
|
$45,676
$19.27 P/Share
|
|
Oct 21
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,786
-1.37%
|
$50,148
$18.28 P/Share
|
|
Oct 21
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
2,771
-4.48%
|
$49,878
$18.29 P/Share
|
|
Oct 20
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
811
-0.4%
|
$14,598
$18.01 P/Share
|
|
Oct 20
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
905
-1.44%
|
$16,290
$18.07 P/Share
|